Abbott Launches First Fully Absorbing Stent In US Market
This article was originally published in The Gray Sheet
Abbott looks to Absorb GT1, the first fully bioresorbable coronary scaffold to gain FDA approval, to help accelerate growth. But it still has yet to be shown superior to conventional drug-eluting stents, and it also has metal stents with bioresorbable polymers to contend with.
Register for our free email digests: